DraftKings Announces Redemption of Public Warrants
BOSTON, May 27, 2020 (GLOBE NEWSWIRE) — DraftKings Inc. (Nasdaq: DKNG) today announced that it will redeem all of its […]
Black Diamond Therapeutics to Present at the Jefferies Virtual Healthcare Conference
CAMBRIDGE, Mass. and NEW YORK, May 27, 2020 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology […]
Ferrari Announces Settlement of its Notes offering
Maranello (Italy), 27 May 2020 – Ferrari N.V. (NYSE/MTA: RACE) announces the settlement of the offering, previously announced, of Euro […]
Trius Announces Stock Option Grant
FREDERICTON, New Brunswick , May 27, 2020 (GLOBE NEWSWIRE) — Trius Investments Inc. (TSXV:TRU.H) (“Trius”) announces that, subject to regulatory […]
Par Pacific Holdings Announces Private Offering of $100 Million of Senior Secured Notes Due 2026
HOUSTON, May 27, 2020 (GLOBE NEWSWIRE) — Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific” or the “Company”) today announced […]
Canadian Metals Project Update: Seeks Opportunities into CO2 Capture and Neutralization Industry Sector
MONTREAL, May 27, 2020 (GLOBE NEWSWIRE) — Canadian Metals Inc. (“CME” or the “Company”) (CSE: CME) announced a management and […]
Cytokinetics and The ALS Association Renew Partnership to Advance the Fight Against ALS
SOUTH SAN FRANCISCO, Calif., and WASHINGTON, May 27, 2020 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq:CYTK) and The ALS Association today […]
Crinetics Pharmaceuticals Appoints Adriana Cabré, MBA, as Vice President of Human Resources
SAN DIEGO, May 27, 2020 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on […]
Bellicum to Participate in Two Upcoming Virtual Investor Conferences
HOUSTON, May 27, 2020 (GLOBE NEWSWIRE) — Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for […]
Verrica Pharmaceuticals to Present at the Jefferies 2020 Healthcare Conference
WEST CHESTER, Pa., May 27, 2020 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing […]
